Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

Treatment Based on ABC-AF Risk Scores Doesn’t Improve AF Outcomes

News Conference News ESC 2025

Treatment Based on ABC-AF Risk Scores Doesn’t Improve AF Outcomes

September 08, 2025

AMALFI: Modest AF Detection With ECG Patch Screening

News Conference News ESC 2025

AMALFI: Modest AF Detection With ECG Patch Screening

Michael O'Riordan

September 05, 2025

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

News Conference News ESC 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

September 06, 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

News Conference News ESC 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

September 06, 2024

Complete Revascularization Better for Older STEMI Patients: Meta-analysis

News Conference News ESC 2024

Complete Revascularization Better for Older STEMI Patients: Meta-analysis

September 04, 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

September 04, 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

SHAM-PVI Catheter Ablation Improves Objective Measure of AF Burden

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

September 02, 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

September 01, 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

August 31, 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

August 31, 2024

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

News Conference News ESC 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

Michael O'Riordan

September 05, 2023

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

News Conference News ESC 2023

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

Michael O'Riordan

August 28, 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

August 26, 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

News Conference News ESC 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

September 01, 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

August 30, 2022

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.